Actions of dopaminergic antagonists in the striatum.
D000928:Antidepressive Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D002250:Carbon Radioisotopes; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D003984:Dibenzazepines / Q000494:pharmacology; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism; D018492:Dopamine Antagonists; D006213:Hallucinogens / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D009638:Norepinephrine / Q000096:biosynthesis; D010640:Phenothiazines; D010649:Phenylalanine / Q000378:metabolism; D011955:Receptors, Drug; D013892:Thioxanthenes / Q000494:pharmacology; D014443:Tyrosine / Q000378:metabolism
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002090:Butyrophenones; D002250:Carbon Radioisotopes; D003984:Dibenzazepines; D018492:Dopamine Antagonists; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D011955:Receptors, Drug; D013892:Thioxanthenes; D014443:Tyrosine; D010649:Phenylalanine; D004298:Dopamine; D009638:Norepinephrine